Startseite>>Signaling Pathways>> Immunology/Inflammation>>β-Glucogallin

β-Glucogallin (Synonyms: 1-O-Galloyl-β-D-glucose)

Katalog-Nr.GC49769

A plant metabolite and an aldose reductase 2 inhibitor

Products are for research use only. Not for human use. We do not sell to patients.

β-Glucogallin Chemische Struktur

Cas No.: 13405-60-2

Größe Preis Lagerbestand Menge
10 mg
100,00 $
Auf Lager
50 mg
425,00 $
Auf Lager
100 mg
752,00 $
Auf Lager
250 mg
1.502,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

β-Glucogallin is a plant metabolite that has been found in E. officinalis and an aldose reductase 2 inhibitor (IC50 = 17 µM).1 β-Glucogallin (30 µM) inhibits glucose-induced sorbitol accumulation in lenses isolated from a transgenic mouse model overexpressing AKR1B1, the gene encoding human aldose reductase 2. It also reduces methylglyoxal-induced increases in COX-2, IL-6, IL-8, chemokine (C-C motif) ligand 2 (CCL2), and receptor for advanced glycation end products (RAGE) levels in ARPE-19 retinal epithelial cells.2

1.Puppala, M., Ponder, J., Suryanarayana, P., et al.The isolation and characterization of β-glucogallin as a novel aldose reductase inhibitor from Emblica officinalisPLoS One7(4)e31399(2012) 2.Ma, Y., Liu, F., and Xu, Y.Protective effect of β-glucogallin on damaged cataract against methylglyoxal induced oxidative stress in cultured lens epithelial cellsMed. Sci. Monit.259310-9318(2019)

Bewertungen

Review for β-Glucogallin

Average Rating: 5 ★★★★★ (Based on Reviews and 33 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for β-Glucogallin

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.